Digipharm Announces Partnership with Swiss Blockchain Giant, Swisscom

With over 11.6bil CH (12.2bil USD) revenue in 2017, Swisscom is Switzerland’s leading telecommunications company and one of its leading IT companies. Two-thirds of the Swiss population use the Swisscom Network, and 51.0% of the company is owned by the Swiss Confederation.

Ahmed Abdulla, Founder and CEO of Digipharm commented “Our alliance with Swisscom Blockchain as our technical development partners is somewhat unprecedented in the industry and a big step towards the application of Digipharms’ solutions in real world settings. With this agreement we are able to accelerate the development of robust, scalable platforms with the highest levels of credibility, data privacy and inherent security. We are working extremely hard, hand in hand with the world class team at Swisscom Blockchain to bring fair pricing to healthcare and push the transition towards personalised therapy. This is massive news for the Digipharm team, our industry partners, investors and most importantly, healthcare systems and patients.”

As a forerunner in innovation and tech, Swisscom announced their venture into blockchain technology in September 2017, with the goal of furthering the development of blockchain applications in and for Switzerland. Since the announcement, Swisscom Blockchain has been approached by hundreds of blockchain-based startups, but they have remained highly selective about whom they choose to work with. Digipharm is collaborating with Swisscom Blockchain in the areas of development, infrastructure, and overall strategy. Our minimal viable product is currently in development, and will be ready for launch immediately following our Initial Coin Offering.

Sven Möller, Swisscom Blockchain Head of ICO Advisory said “Swisscom Blockchain is proud to be in cooperation with Digipharm in the development of their game-changing platforms. We believe their platforms and vision are well placed to lead the advance of real world uptake for blockchain technology in healthcare. We are convinced that our work together can make an impact on the global scale and we are delighted to support innovation at a local level. Our team of experts will work side by side with the Digipharm team to bring their vision to life, bring fair pricing to healthcare and benefit patients all over the world.”